These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21476378)

  • 41. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
    Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
    Gilmore R; Doyle M; Holden F; White B; O'Donnell J
    Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Kirienko AI
    Angiol Sosud Khir; 2010; 17(1):87-94. PubMed ID: 21780625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].
    Vorob'eva NM; Panchenko EP; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invited commentary.
    Henke PK
    J Vasc Surg; 2010 Nov; 52(5):1270-1. PubMed ID: 21050988
    [No Abstract]   [Full Text] [Related]  

  • 46. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wells' prediction rules for pulmonary embolism: valid in all clinical subgroups?
    Sharif-Kashani B; Bikdeli B; Ehteshami-Afshar S; Chitsazan M; Behzadnia N; Chitsaz E; Kermani-Randjbar S; Saliminejad L; Masjedi MR; Bikdeli B
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):614-8. PubMed ID: 22885764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Travel, venous thromboembolism, and thrombophilia.
    Gallus AS
    Semin Thromb Hemost; 2005 Feb; 31(1):90-6. PubMed ID: 15706480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
    Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
    Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between inherited thrombophilia and impaired right ventricular function in deep vein thrombosis without symptomatic pulmonary embolism.
    Asgun HF; Kirilmaz B; Saygi S; Ozturk O; Silan F; Karatag O; Kosar S; Ozdemir O
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):270-7. PubMed ID: 22992348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controversies in pulmonary embolism and deep venous thrombosis.
    Davidson BL
    Am Fam Physician; 1999 Nov; 60(7):1969-80. PubMed ID: 10569501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment.
    Vítovec M; Golán L; Roztocil K; Linhart A
    Vasa; 2009 Aug; 38(3):238-44. PubMed ID: 19736635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of a retrievable vena cava filter with low-intensity anticoagulation for prevention of pulmonary embolism in patients with cancer: an observational study in 106 cases.
    Damascelli B; Ticha V; Patelli G; Lanocita R; Morosi C; Civelli E; Di Tolla G; Frigerio LF; Ciceri E; Garbagnati F; Spreafico C; Amadeo P; Marchianò A
    J Vasc Interv Radiol; 2011 Sep; 22(9):1312-9. PubMed ID: 21680201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Massive pulmonary embolism in a woman with leiomyomatous uterus causing pelvic deep venous thrombosis.
    Falcone M; Serra P
    Ann Ital Med Int; 2005; 20(2):104-7. PubMed ID: 16052843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
    Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
    Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.